4 11

Adjunctive Cilostazol Versus Double-Dose Clopidogrel After Drug-Eluting Stent Implantation

Authors
 Kyung Woo Park  ;  Si-Hyuck Kang  ;  Jin Joo Park  ;  Han-Mo Yang  ;  Hyun-Jae Kang  ;  Bon-Kwon Koo  ;  Byoung-Eun Park  ;  Kwang Soo Cha  ;  Jay Young Rhew  ;  Hui-Kyoung Jeon  ;  Eun Seok Shin  ;  Ju Hyeon Oh  ;  Myung-Ho Jeong  ;  Sanghyun Kim  ;  Kyung-KukHwang  ;  Jung-Han Yoon  ;  Sung Yun Lee  ;  Tae-Ho Park  ;  Keon Woong Moon  ;  Hyuck-Moon Kwon  ;  In-Ho Chae  ;  Hyo-Soo Kim 
Citation
 JACC. Cardiovascular Interventions, Vol.6(9) : 932-942, 2013 
Journal Title
 JACC. Cardiovascular Interventions 
ISSN
 1936-8798 
Issue Date
2013
MeSH
Aged ; Aspirin/administration & dosage ; Coronary Artery Disease/diagnosis ; Coronary Artery Disease/mortality ; Coronary Artery Disease/therapy* ; Coronary Thrombosis/etiology ; Drug Therapy, Combination ; Drug-Eluting Stents* ; Female ; Hemorrhage/chemically induced ; Humans ; Male ; Middle Aged ; Myocardial Infarction/etiology ; Percutaneous Coronary Intervention/adverse effects ; Percutaneous Coronary Intervention/instrumentation* ; Percutaneous Coronary Intervention/mortality ; Platelet Aggregation Inhibitors/administration & dosage* ; Platelet Aggregation Inhibitors/adverse effects ; Prospective Studies ; Prosthesis Design ; Republic of Korea ; Risk Factors ; Stroke/etiology ; Tetrazoles/administration & dosage* ; Tetrazoles/adverse effects ; Ticlopidine/administration & dosage ; Ticlopidine/adverse effects ; Ticlopidine/analogs & derivatives* ; Time Factors ; Treatment Outcome
Keywords
ACS ; CI ; DDAT ; HOPR ; MI ; OPR ; PCI ; TAT ; acute coronary syndromes ; antiplatelet therapy ; cliostazol ; clopidogrel ; confidence interval ; double-dose clopidogrel dual antiplatelet therapy ; high on-treatment platelet reactivity ; myocardial infarction ; on-treatment platelet reactivity ; percutaneous coronary intervention ; randomized controlled trial ; triple antiplatelet therapy
Abstract
OBJECTIVES: This study sought to test the noninferiority of triple antiplatelet therapy (TAT) versus double-dose clopidogrel dual antiplatelet therapy (DDAT) in patients undergoing percutaneous coronary intervention (PCI). BACKGROUND: Antiplatelet regimen is an integral component of medical therapy after PCI. A 1-week duration of doubling the dose of clopidogrel was shown to improve outcome at 1 month compared with the conventional dose in patients with acute coronary syndrome undergoing PCI. Yet in Asia, the addition of cilostazol is used more commonly than DDAT in high-risk patients. METHODS: We randomly assigned 3,755 all-comers undergoing PCI to either TAT or DDAT, which was continued for 1 month, to test the noninferiority of TAT versus DDAT. The primary outcome was the cumulative incidence of net clinical outcome at 1 month post-PCI defined as the composite of cardiac death, nonfatal myocardial infarction, stent thrombosis, stroke, and PLATO (Platelet Inhibition and Patient Outcomes) major bleeding. RESULTS: TAT was noninferior to DDAT with respect to the primary outcome, which occurred in 1.2% and 1.4% of patients, respectively (-0.22% absolute difference, 0.34% 1-sided 97.5% confidence interval, p = 0.0007 for noninferiority; hazard ratio: 0.85; 95% confidence interval: 0.49 to 1.48; p = 0.558 for superiority). The individual risks of cardiac death, nonfatal myocardial infarction, stent thrombosis, stroke, and PLATO major bleeding did not differ significantly between the 2 groups. There were no significant between-group differences in the treatment effect with regard to the rate of the primary outcome. CONCLUSIONS: The adjunctive use of cilostazol was noninferior to doubling the dose of clopidogrel for 1 month in all-comers undergoing PCI with exclusively drug-eluting stents. (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-SAfety & EffectiveneSS of Drug-ElUting Stents & Anti-platelet REgimen [HOST-ASSURE]; NCT01267734).
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/165658
Files in This Item:
T201306418.pdf Download
DOI
10.1016/j.jcin.2013.04.022
Appears in Collections:
1. Journal Papers (연구논문) > 1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실)
Yonsei Authors
권혁문(Kwon, Hyuck Moon)
Export
RIS (EndNote)
XLS (Excel)
XML
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse